{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:10:24Z","timestamp":1771920624039,"version":"3.50.1"},"reference-count":16,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T00:00:00Z","timestamp":1505174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To provide a comparison of the outcome of infective endocarditis (IE) in patients undergoing transcatheter pulmonary valve replacement (TPVR) versus surgical pulmonary valve replacement (SPVR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>Although TPVR is thought to be associated with a higher risk of IE than SPVR, there is paucity of data to support this.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients who underwent TPVR or SPVR at UCLA between October 2010 and September 2016 were included and retrospectively analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Three hundred forty\u2010two patients underwent PVR at UCLA including 134 SPVR and 208 TPVR. Patients undergoing TPVR were more likely to have had a history of endocarditis than those undergoing SPVR (5.3% vs. 0.7%, <jats:italic>P =<\/jats:italic> 0.03) and a right ventricle to pulmonary artery (RV to PA) conduit (37% vs. 17%, <jats:italic>P =<\/jats:italic> 0.0001). Two SPVR and seven TPVR patients developed IE with a 4\u2010year freedom from endocarditis of 94.0% in the SPVR versus 84% in the TPVR group (<jats:italic>P =<\/jats:italic> 0.13). In patients who underwent TPVR and developed endocarditis, the mean gradient across the RVOT prior to intervention was higher (28.1\u2009\u00b1\u20094.5 vs. 17.4\u2009\u00b1\u20090.6 mmHg, <jats:italic>P =<\/jats:italic> 0.02) and were more likely to have a conduit (71% vs. 36%, <jats:italic>P =<\/jats:italic> 0.049).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this study, patients undergoing TPVR were not at a higher risk of IE than patients undergoing SPVR. TPVR patients were more likely to have had a prior history of IE and RV\u2010PA conduit. The patients at highest risk were those with stenotic RV to PA conduits who were treated with TPVR.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ccd.27312","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T07:00:56Z","timestamp":1505199656000},"page":"277-284","source":"Crossref","is-referenced-by-count":20,"title":["Incidence and outcome of infective endocarditis following percutaneous versus surgical pulmonary valve replacement"],"prefix":"10.1002","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4000-8993","authenticated-orcid":false,"given":"Gentian","family":"Lluri","sequence":"first","affiliation":[{"name":"Department of Medicine Division of Cardiology, David Geffen School of Medicine at UCLA, Ahmanson\/UCLA Adult Congenital Heart Disease Center Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Levi","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Cardiology, David Geffen School of Medicine at UCLA, Ahmanson\/UCLA Adult Congenital Heart Disease Center Los Angeles California"},{"name":"Department of Pediatrics Division of Cardiology, David Geffen School of Medicine at UCLA Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Cardiology, David Geffen School of Medicine at UCLA, Ahmanson\/UCLA Adult Congenital Heart Disease Center Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbie","family":"Hageman","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Cardiology, David Geffen School of Medicine at UCLA, Ahmanson\/UCLA Adult Congenital Heart Disease Center Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Division of Cardiology, David Geffen School of Medicine at UCLA Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Sadeghi","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Cardiology, David Geffen School of Medicine at UCLA, Ahmanson\/UCLA Adult Congenital Heart Disease Center Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Reemtsen","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery David Geffen School of Medicine at UCLA Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillel","family":"Laks","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery David Geffen School of Medicine at UCLA Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reshma","family":"Biniwale","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery David Geffen School of Medicine at UCLA Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morris","family":"Salem","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Division of Cardiology, Kaiser Permanente Los Angeles Medical Center Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Fishbein","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine David Geffen School of Medicine at UCLA Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil","family":"Aboulhosn","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Cardiology, David Geffen School of Medicine at UCLA, Ahmanson\/UCLA Adult Congenital Heart Disease Center Los Angeles California"},{"name":"Department of Pediatrics Division of Cardiology, David Geffen School of Medicine at UCLA Los Angeles California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,9,12]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.001827"},{"key":"e_1_2_7_3_1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s15010-012-0326-6","article-title":"Infective endocarditis in congenital heart disease: A frequent community\u2010acquired complication","volume":"41","author":"Fortun J","year":"2013","journal-title":"Infection"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02844-0"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.112.972216"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.26398"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.24518"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.013588"},{"key":"e_1_2_7_9_1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/heartjnl-2014-306761","article-title":"Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants","volume":"101","author":"Dijck I","year":"2015","journal-title":"Heart"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2014.07.097"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1086\/313753"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2014.10.003"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2010.05.019"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2008.11.029"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.112.000087"},{"key":"e_1_2_7_16_1","unstructured":"Edwards Lifesciences Corporation Irvine California.2016. Edwards SAPIEN XT Transcatheter Heart Valve with the NovaFlex\u2009+\u2009Delivery System. Vol. 2016. Retrieved fromhttps:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf13\/p130009s037d.pdf. Last accessed August 16 2017."},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.07.004"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.27312","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.27312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T07:37:25Z","timestamp":1695713845000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.27312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,12]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1002\/ccd.27312"],"URL":"https:\/\/doi.org\/10.1002\/ccd.27312","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,12]]}}}